Leveraging Stem Cells to Create Better Disease Models
Webinar

Leveraging Stem Cells to Create Better Disease Models

Clive Svendsen, Meritxell Huch, Ameen Salahudeen, and Maksim Plikus will discuss the latest advances in using patient-derived stem cells to create more accurate disease models.

Share

 LIVE Symposium

Friday, August 4, 2023
11:00 AM - 2:00 PM Eastern Time

Register now to receive a custom desktop and cellphone background from The Scientist's Symposium Team!

Individualized disease models are key tools for studying the molecular and cellular mechanisms that underlie a patient’s symptoms and identifying treatment options. Researchers previously struggled to create personalized models that accurately mimicked disease hallmarks because they lacked cell culture methods that recreated a cell’s physiological and biomechanical environment. Recent advances in organoid and organ-on-a-chip technologies permit scientists to develop miniature in vitro organ models, promising to unlock new insights into how organs function under normal and pathogenic conditions. 

In this symposium brought to you by The Scientist, Clive Svendsen, Meritxell Huch, Ameen Salahudeen, and Maksim Plikus discuss how to leverage patient-derived stem cells to create more accurate disease models for cancer, infectious disease, and hereditary conditions. They will explore how to employ such models to develop precision medicine approaches that screen for effective therapeutics prior to treatment. 

Symposium program

11:00 AM – Introduction

11:10 AM – Using Induced Pluripotent Stem Cells to Model Human Disease

Clive Svendsen, PhD

11:45 AM – Tissue-derived Organoid Models and their Biomedical Applications

Meritxell Huch, PhD

12:20 PM – Investigating pulmonary disease via organoid models coupled with spatial technologies

Ameen Salahudeen, MD, PhD

12:55 PM – Engineering New Functional Skin to Treat Wounds, Scars and Hair Loss 

Maksim Plikus, PhD

1:30 PM - Open panel Q&A session
Iris Kulbatski from The Scientist's Creative Services Team will be joined by the entire panel in an open question and answer session where presenters will address questions posed by the audience.

Clive

Clive Svendsen, PhD
Professor
Biomedical Sciences and Medicine
Executive Director
Board of Governors Regenerative Medicine Institute
Cedars-Sinai Medical Center

Huch

Meritxell Huch, PhD
Director and Scientific Member 
Max Planck Institute of Molecular Cell Biology and Genetics 


Ameen

Ameen Salahudeen, MD, PhD
Assistant Professor 
Department of Internal Medicine
University of Illinois College of Medicine
Scientific Director
Biological Modeling
Tempus Labs, Inc.


Maksim

Maksim Plikus, PhD
Professor
Department of Developmental and Cell Biology
University of California, Irvine

Sponsored by

Silver Sponsors

SinoBiological Synthego  


Top Image Credit:

Leveraging Stem Cells to Create Better Disease Models

Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies